Papillary plasma flow in rats. II. Hormonal control.

Area of Science:

• Physiology
• Endocrinology
• Pharmacology

Background:

• Sex differences in papillary plasma flow (PPF) are significant, with males exhibiting lower flow than females.
• Hormonal and vasoactive factors are implicated in regulating PPF, but their specific roles remain unclear.

Purpose of the Study:

• To investigate the influence of sex hormones, angiotensin II (AII), prostaglandins (PGs), and pharmacological agents on papillary plasma flow (PPF) in Wistar rats.
• To elucidate the mechanisms underlying sex-based differences in PPF and the effects of captopril and indomethacin.

Main Methods:

• Papillary plasma flow (PPF) was quantified using the albumin accumulation technique in male and female Wistar rats.
• Experimental manipulations included castration, testosterone administration, indomethacin and captopril treatment, dehydration, and angiotensin II infusion.
• Measurements were taken under various physiological and pharmacological conditions to assess their impact on PPF.

Main Results:

• Male rats showed significantly lower PPF than females; castration increased PPF in males, while testosterone decreased it.
• Indomethacin reduced PPF in both sexes, whereas captopril increased it in males and maintained high levels in females, normalizing flow.
• Dehydration decreased PPF, an effect blunted by captopril. Angiotensin II infusion did not restore PPF in captopril-treated males, but AII combined with indomethacin did.

Conclusions:

• Male sex hormones and angiotensin II contribute to reduced papillary plasma flow (PPF) in male rats.
• Vasodilator prostaglandins play a crucial role in the higher PPF observed in female rats.
• Captopril exerts its vasodilatory effect on papillary circulation through both reduced AII formation and enhanced PG synthesis.